Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"Multicenter Study"
topic_facet:"hemoglobin A1c protein, human"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&filter%5B%5D=topic_facet%3A%22hemoglobin+A1c+protein%2C+human%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&filter%5B%5D=topic_facet%3A%22hemoglobin+A1c+protein%2C+human%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&filter%5B%5D=topic_facet%3A%22hemoglobin+A1c+protein%2C+human%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (64)
1
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment : A randomized open label study
enthalten in:
Diabetes, obesity & metabolism
| 2024
von
Christofides, E.
|
Puente, O.
|
Norwood, P.
| +19
Wird geladen...
2
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
enthalten in:
Diabetes, obesity & metabolism
| 2024
von
Lim, S.
|
Lee, S.
|
Min, K.
| +12
Wird geladen...
3
Superior HbA1c control with the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double-blind, randomized trial
enthalten in:
Diabetes, obesity & metabolism
| 2019
von
Watada, H.
|
Kaneko, S.
|
Komatsu, M.
| +4
Wird geladen...
4
Empagliflozin compared with glimepiride in metformin-treated patients with type 2 diabetes : 208-week data from a masked randomized controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Ridderstråle, M.
|
Rosenstock, J.
|
Andersen, K.
| +3
Wird geladen...
5
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes : Efficacy and safety from a randomized double-blind trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Buse, J.
|
Carlson, A.
|
Komatsu, M.
| +6
Wird geladen...
6
Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Chen, Y.
|
Huang, C.
|
Cho, Y.
| +5
Wird geladen...
7
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes : A randomized, open-label clinical trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Hollander, P.
|
Carofano, W.
|
Lam, R.
| +8
Wird geladen...
8
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes : A randomized, open-label clinical trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Home, P.
|
Lam, R.
|
Carofano, W.
| +7
Wird geladen...
9
Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes : Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Kawamori, R.
|
Haneda, M.
|
Suzaki, K.
| +7
Wird geladen...
10
Efficacy and safety of MYL-1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks : Results of the INSTRIDE 1 phase III study
enthalten in:
Diabetes, obesity & metabolism
| 2018
von
Blevins, T.
|
Barve, A.
|
Sun, B.
| +1
Wird geladen...
1
2
3
4
5
6
7
Nächster »
[7]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: Multicenter Study
Filter aufheben
Thema: hemoglobin A1c protein, human
Medienart
64
Aufsätze
64
E-Artikel
64
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
64
Clinical Trial, Phase III
Multicenter Study
hemoglobin A1c protein, human
63
Journal Article
63
Randomized Controlled Trial
62
Glycated Hemoglobin A
58
Hypoglycemic Agents
56
Research Support, Non-U.S. Gov't
44
Blood Glucose
34
type 2 diabetes
25
9100L32L2N
25
Metformin
23
Comparative Study
16
2ZM8CX04RZ
16
Insulin Glargine
15
phase III study
12
Dipeptidyl-Peptidase IV Inhibitors
11
Glucosides
11
glycaemic control
10
Sulfonylurea Compounds
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2020-
62
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
64
Englisch
Haven't found what you're looking for?
Wird geladen...